BMO Capital Maintains Market Perform on Zimmer Biomet Holdings, Lowers Price Target to $101
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
BMO Capital analyst Vik Chopra maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Market Perform and lowers the price target from $102 to $101.
BMO Capital analyst Vik Chopra maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Market Perform and lowers the price target from $102 to $101.
